• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于结直肠癌循环肿瘤细胞的KRAS免疫脂质磁球的构建与表征

Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells.

作者信息

Feng Chengbao, Wang Jingjing, Yang Xue, Zang Xuefang, Zhou Haikun, Zhang Erying, Li Haifei, Liu Bo, Chen Shumin, Wang Ying, Wang Peng, Gao Lixue, Liu Jinyan

机构信息

Department of Medical Oncology, No. 2 Hospital of Baoding, Baoding City, People's Republic of China.

Baoding Children's Hospital, Baoding City, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Oct 13;12:10067-10075. doi: 10.2147/CMAR.S258565. eCollection 2020.

DOI:10.2147/CMAR.S258565
PMID:33116863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568589/
Abstract

OBJECTIVE

The purpose of this study was to prepare and characterize a lipid magnetic ball modified with KRAS antibodies on the surface and to isolate circulating tumor cells of colorectal cancer with mutations.

METHODS

The microemulsion method was used to form lipid bilayers to encapsulate Fe3O4 nanoparticles with superparamagnetism to form lipid magnetic balls, and antibodies were formed on the surface to form immune lipid magnetic balls.

RESULTS

Compared with traditional EpCAM antibody-modified lipid magnetic balls, it can effectively improve the capture ability of colorectal cancer circulating tumor cells with mutation, the capture rate reaches 92.9%, and the capture results are consistent with clinical diagnosis and pathology.

CONCLUSION

Our results showed that antibody-modified lipid magnetic balls can be used in the diagnosis and treatment of colorectal cancer.

摘要

目的

本研究旨在制备并表征表面修饰有KRAS抗体的脂质磁球,并分离出具有突变的结直肠癌循环肿瘤细胞。

方法

采用微乳液法形成脂质双层以包裹具有超顺磁性的Fe3O4纳米颗粒,从而形成脂质磁球,并在表面形成抗体以形成免疫脂质磁球。

结果

与传统的EpCAM抗体修饰的脂质磁球相比,它能有效提高对具有突变的结直肠癌循环肿瘤细胞的捕获能力,捕获率达到92.9%,且捕获结果与临床诊断及病理结果一致。

结论

我们的结果表明,抗体修饰的脂质磁球可用于结直肠癌的诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/76f9c1c85109/CMAR-12-10067-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/7bb4f892dc11/CMAR-12-10067-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/d6341fd598c4/CMAR-12-10067-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/81e78a30283a/CMAR-12-10067-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/5fb1f5156a3c/CMAR-12-10067-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/07d00c49fdd0/CMAR-12-10067-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/76f9c1c85109/CMAR-12-10067-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/7bb4f892dc11/CMAR-12-10067-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/d6341fd598c4/CMAR-12-10067-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/81e78a30283a/CMAR-12-10067-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/5fb1f5156a3c/CMAR-12-10067-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/07d00c49fdd0/CMAR-12-10067-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4f/7568589/76f9c1c85109/CMAR-12-10067-g0006.jpg

相似文献

1
Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells.用于结直肠癌循环肿瘤细胞的KRAS免疫脂质磁球的构建与表征
Cancer Manag Res. 2020 Oct 13;12:10067-10075. doi: 10.2147/CMAR.S258565. eCollection 2020.
2
Epidermal growth factor receptor-targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently.表皮生长因子受体靶向免疫磁性脂质体高效捕获循环结直肠肿瘤细胞。
World J Gastroenterol. 2018 Jan 21;24(3):351-359. doi: 10.3748/wjg.v24.i3.351.
3
Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer.检测转移性结直肠癌患者循环肿瘤细胞中的KRAS突变。
Cancer Biol Ther. 2015;16(9):1289-95. doi: 10.1080/15384047.2015.1070991. Epub 2015 Aug 7.
4
KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.通过液滴数字PCR检测结直肠癌患者循环游离DNA中的KRAS G12V突变
Int J Mol Sci. 2016 Apr 1;17(4):484. doi: 10.3390/ijms17040484.
5
Colorectal cancer patients with low abundance of KRAS mutation may benefit from EGFR antibody therapy.结直肠癌患者 KRAS 突变丰度低可能受益于 EGFR 抗体治疗。
PLoS One. 2013 Jul 9;8(7):e68022. doi: 10.1371/journal.pone.0068022. Print 2013.
6
Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer.利用结直肠癌患者循环游离DNA检测KRAS突变的效用
Cancer Sci. 2016 Jul;107(7):936-43. doi: 10.1111/cas.12959. Epub 2016 Jun 13.
7
KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer.转移性结直肠癌患者治疗期间循环肿瘤细胞的KRAS基因分型变化
PLoS One. 2014 Aug 19;9(8):e104902. doi: 10.1371/journal.pone.0104902. eCollection 2014.
8
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer.结直肠癌中KRAS突变导致的耐药性的数学建模
J Theor Biol. 2016 Jan 21;389:263-73. doi: 10.1016/j.jtbi.2015.10.019. Epub 2015 Nov 6.
9
Enhancing detection of circulating tumor cells with activating KRAS oncogene in patients with colorectal cancer by weighted chemiluminescent membrane array method.加权化学发光膜阵列法增强结直肠癌患者 KRAS 癌基因突变的循环肿瘤细胞检测。
Ann Surg Oncol. 2010 Feb;17(2):624-33. doi: 10.1245/s10434-009-0831-8.
10
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.分析循环DNA和蛋白质生物标志物以预测瑞戈非尼的临床活性并评估转移性结直肠癌患者的预后:CORRECT试验的回顾性探索性分析
Lancet Oncol. 2015 Aug;16(8):937-48. doi: 10.1016/S1470-2045(15)00138-2. Epub 2015 Jul 13.

引用本文的文献

1
Magnetic-Assisted Manipulation of Rare Blood Cells for Diagnosis: A Systematic Review.用于诊断的稀有血细胞的磁辅助操作:一项系统综述
Biotechnol Bioeng. 2025 Jun 26. doi: 10.1002/bit.70010.
2
Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells.基于液体活检的循环肿瘤细胞表面标志物用于结直肠癌筛查
Diagnostics (Basel). 2021 Nov 17;11(11):2136. doi: 10.3390/diagnostics11112136.

本文引用的文献

1
CTC analysis: an update on technological progress.CTC 分析:技术进展更新。
Transl Res. 2019 Oct;212:14-25. doi: 10.1016/j.trsl.2019.07.003. Epub 2019 Jul 11.
2
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion.用于研究癌症免疫逃逸的循环肿瘤细胞的分子特征分析
Methods Mol Biol. 2019;1884:247-258. doi: 10.1007/978-1-4939-8885-3_17.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.循环肿瘤细胞的上皮-间充质转化和 GALC 表达预示着非小细胞肺癌的转移和不良预后。
Cancer Biomark. 2018;22(3):417-426. doi: 10.3233/CBM-170995.
5
Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol.拓扑异构酶 1 阳性循环肿瘤细胞的变化影响依替立康聚乙二醇治疗晚期乳腺癌患者的总生存。
Clin Cancer Res. 2018 Jul 15;24(14):3348-3357. doi: 10.1158/1078-0432.CCR-17-3059. Epub 2018 Apr 4.
6
Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.循环肿瘤细胞上皮-间充质转化表型与结直肠癌患者临床病理特征的相关性。
Dis Markers. 2017;2017:9474532. doi: 10.1155/2017/9474532. Epub 2017 Dec 21.
7
Epidermal growth factor receptor-targeted immune magnetic liposomes capture circulating colorectal tumor cells efficiently.表皮生长因子受体靶向免疫磁性脂质体高效捕获循环结直肠肿瘤细胞。
World J Gastroenterol. 2018 Jan 21;24(3):351-359. doi: 10.3748/wjg.v24.i3.351.
8
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
9
K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.K-ras 突变通过组织蛋白酶 L/CUX1 通路促进肺癌放射诱导的侵袭和迁移。
Exp Cell Res. 2018 Jan 15;362(2):424-435. doi: 10.1016/j.yexcr.2017.12.006. Epub 2017 Dec 12.
10
MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.微小 RNA 对胰腺癌中 K-Ras 的调控及治疗干预的机会。
Semin Cancer Biol. 2019 Feb;54:63-71. doi: 10.1016/j.semcancer.2017.11.020. Epub 2017 Dec 2.